Drug intelligence / Profile preview

SBI-425

Development stage
Preclinical
Lead developer
Sanford Burnham Prebys Medical Discovery Institute
Modality
Small Molecules
Administration
Oral, Intraperitoneal, Intravenous
01

Overview

SBI-425 is a small molecule, potent, selective, and orally bioavailable inhibitor of tissue-nonspecific alkaline phosphatase (TNAP). It effectively inhibits TNAP activity both in vitro and in vivo, with potential therapeutic applications in diseases involving inappropriate calcification, such as vascular calcification and certain genetic conditions. SBI-425 was developed by the Sanford Burnham Prebys Medical Discovery Institute. The drug is being researched for its ability to inhibit calcification in vascular models and has shown promise in reducing arterial media calcification in animal studies. SBI-425 does not significantly affect calcium or phosphorus metabolism but may have effects on bone mineralization.

Other names
5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide
02

Targets

ALPL (Tissue-nonspecific alkaline phosphatase)

Beyond the preview

Go deeper on SBI-425.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SBI-425.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call